Kevin C. Johnson

All filings by Kevin C. Johnson on record concern Neogenomics Inc, in the capacity of board member. The record holds 22 filings, for trades running from 15 April 2014 to 22 December 2021.

Both buying and selling appear: 3 purchases worth €400k, against 5 sales worth €3.2M. Netting one side against the other leaves €2.8M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 7 share grants and 7 option exercises.

In size, the median ticket on the buying side is €92k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +28.8%. This is a record of the past, not a forecast.

Most recently, on 23 December 2021, the filings show an option exercise worth €21k in Neogenomics Inc. The most recent open-market purchase was published on 26 December 2018, 2,875 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.